Clinico-microbiological profile of healthcare associated pneumonia in critically ill patients at level-I trauma centre of India

Minu Kumari; Neha Rastogi; Rajesh Malhotra; Purva Mathur

doi:10.4103/JLP.JLP_85_18

Journal of Laboratory Physicians, Table of Contents

CC BY-NC-ND 4.0 · J Lab Physicians 2018; 10(04): 406-409
DOI: 10.4103/JLP.JLP_85_18

Original Article

Clinico-microbiological profile of healthcare associated pneumonia in critically ill patients at level-I trauma centre of India

Minu Kumari

Division of Trauma Surgery and Critical Care, JPNATC, AIIMS, New Delhi, India

,

Neha Rastogi

Department of Laboratory Medicine, JPNATC, AIIMS, New Delhi, India

,

Rajesh Malhotra

Department of Orthopaedics, AIIMS, New Delhi, India

,

Purva Mathur

Division of Trauma Surgery and Critical Care, JPNATC, AIIMS, New Delhi, India

› Author Affiliations

Abstract

PDF Download

ABSTRACT

INTRODUCTION: Device-associated infections constitute the majority of health-care infections in Intensive Care Units (ICUs). Trauma patients are more prone to acquire such infections; ventilator-associated pneumonia (VAP) being the most common Health care associated infections (HAI) in ICU has serious implications such as increased morbidity, prolonged hospital stay, and mortality. This study aims to compare the clinicomicrobiological profile of VAP and non-VAP trauma patients at Level I trauma center.

MATERIALS AND METHODS: A 4-year retrospective study of prospectively maintained database was conducted at Level 1 trauma center from January 2013 to December 2016. The patients were classified into two groups named VAP and non-VAP patients. VAP patients were defined according to the criteria of the Centers for Disease Control and Prevention. The data were compiled and analyzed. Statistical data were analyzed using SPSS version 21 software.

RESULTS: During the study period, 134 (13%) cases of VAP and 909 (87%) non-VAP cases were observed in our study. The total number of ventilator days for VAP patients was 5128 days, which ranged from 2 to 82 days (median 42 days). The length of hospital stay in non-VAP category ranged from 1 to 390 days (median 195.5 days). Inhospital mortality was observed in 62 (46%) patients with VAP. Three hundred and eighteen (35%) non-VAP patients had also had a fatal outcome. Gram-negative organisms, most commonly Acinetobacter spp. (13, 21%), were reported in the fatal VAP patients.

CONCLUSION AND DISCUSSION: Higher rate of mortality was observed in patients with VAP in comparison to non-VAP patients, both being on mechanical ventilation. Early recognition of VAP, implementation of proper VAP preventive bundle strategies, and stringent infection control practices are essential mandates to prevent VAP.

Keywords

Antimicrobial - infection - mortality - resistance

PDF (426 kb)

References

REFERENCES
1 Safety WP. World Health Organization, WHO guidelines on hand hygiene in health care. 2009. Available from: http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf. [Last accessed on 2018 Jun 10].
2 Kanj S, Kanafani Z, Sidani N, Alamuddin L, Zahreddine N, Rosenthal V. International nosocomial infection control consortium findings of device-associated infections rate in an Intensive Care Unit of a Lebanese university hospital. J Glob Infect Dis 2012;4:15-21.
3 McFee RB. Nosocomial or hospital-acquired infections: An overview. Dis Mon 2009;55:422-38.
4 Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. American journal of respiratory and critical care medicine. 1999;160:608-13.
5 Available from: https://www.cdc.gov/nhsn/ps-analysis-resources/reference-guides.html. [Last accessed on 2018 May 20].
6 Batra P, Mathur P, John NV, Nair SA, Aggarwal R, Soni KD, et al. Impact of multifaceted preventive measures on ventilator-associated pneumonia at a single surgical centre. Intensive care medicine 2015;41:2231.
7 Hunter JD. Ventilator associated pneumonia. BMJ 2012;344:e3325.
8 Afshari A, Pagani L, Harbarth S. Year in review 2011: Critical care – infection. Crit Care 2012;16:242-7.
9 NNIS System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. A report from the NNIS system. Am J Infect Control 1999;27:520-32.
10 Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome and risk stratification of ventilator-associated pneumonia – A prospective cohort study. Indian J Crit Care Med 2005;9:211-6.
11 Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth 2010;54:535-40.
12 Saldanha Dominic RM, Prashanth HV, Shenoy S, Baliga S. A clinico-microbiological study of ventilator-associated pneumonia in a tertiary care hospital. Int J Biol Med Res 2012;3:1651-4.
13 Gupta A, Agrawal A, Mehrotra S, Singh A, Malik S, Khanna A, et al. Incidence, risk stratification, antibiogram of pathogens isolated and clinical outcome of ventilator associated pneumonia. Indian J Crit Care Med 2011;15:96-101.
14 Koenig SM, Truwit JD. Ventilator-associated pneumonia: Diagnosis, treatment, and prevention. Clin Microbiol Rev 2006;19:637-57.
15 Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP. Ventilator-associated pneumonia in a tertiary care Intensive Care Unit: Analysis of incidence, risk factors and mortality. Indian J Crit Care Med 2014;18:200-4.
16 Mathur P, Tak V, Gunjiyal J, Nair SA, Lalwani S, Kumar S, et al. Device-associated infections at a level-1 trauma centre of a developing nation: Impact of automated surveillance, training and feedbacks. Indian J Med Microbiol 2015;33:51-62.
17 Dey A, Bairy I. Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months’ prospective study. Ann Thorac Med 2007;2:52-7.
18 Rasslan O, Seliem ZS, Ghazi IA, El Sabour MA, El Kholy AA, Sadeq FM, et al. Device-associated infection rates in adult and pediatric Intensive Care Units of hospitals in Egypt. International Nosocomial Infection Control Consortium (INICC) findings. J Infect Public Health 2012;5:394-402.
19 Fathy A, Abdelhafeez R, El-Gilany A, AbdElhafez SA. Analysis of ventilator associated pneumonia (VAP) studies in Egyptian University Hospitals. Egypt J Chest Dis Tuberc 2013;62:17-25.
20 Stanek F, Findeis H, Gebhardt G. A classification apparatus for the classification of direct-current output voltages of the precision noise-impulse-level meters type 00017 and 00023. Z Gesamte Hyg 1979;25:186-7.
21 Khattab AA, El-Lahony DM, Fathy W. Ventilator associated pneumonia in a neonatal Intensive Care Unit. J Am Sci 2013;9:251-8.
22 Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: From epidemiology to patient management. Clin Infect Dis 2004;38:1141-9.